Corporate Fellows

Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.

Jerry is recognized for distinguished research on the genetic basis of tree growth and development, including leading the international efforts to sequence, assemble, and annotate the genomes of poplar and eucalyptus bioenergy feedstocks.

For his pioneering research in atom probe field-ion microscopy and atom probe tomography, most recently to understand the unprecedented properties and behaviors of nanostructured ferritic steels.

For outstanding scientific, programmatic, and institutional contributions to ORNL in advanced computational structural mechanics and nuclear safety technologies.

For pioneering the application of chaos theory and nonlinear dynamics to energy technologies, including gas-fluidized beds, internal combustion engines, and pulsed combustion.

For pioneering research and distinguished contributions to the field of high-temperature superconductors, including fundamental materials science advances and technical innovations that enable commercialization.

For his internationally recognized accomplishments in high-energy physics, radiation transport, and detector and neutron target research and development.

For significant contributions and leadership in the processing and properties of materials, particularly intermetallic alloys, which have led to his reputation as one of the world's leading scientists in these areas.

For distinguished research on the air/surface exchange of atmospheric trace gases and particles and their interactions with the Earth's biogeochemical cycles, and for pioneering developments in atmospheric sampling methodologies with special emphasis on the global mercury cycle.

For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.